Booz Allen Hamilton Holding Cor — BAH
| Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
|---|---|---|---|---|---|---|---|
| $96.35 | $11.88B | 14.7 | 15.9 | 8.1% | 8.9% | $2.20 2.3% | 11.8 |
Latest Headlines
- · Blue Matter Establishes New Capabilities in Biopharma Research & Development Led by Partner, Tara Austraat-Churik
- · A Look At Booz Allen Hamilton (BAH) Valuation After Defense Spending Proposal And New Tech Partnership
- · Is There Now an Opportunity in Booz Allen Hamilton Holding (BAH) After Recent Share Price Weakness
- · Booz Allen Hamilton Holding (BAH) Is Up 8.3% After Becoming a16z’s First Government Tech Partner
- · Does the Kraft Group Partnership Signal Upside for BigBear.ai Stock?
- · Booz Allen Announces Partnership with Andreessen Horowitz to Accelerate and Scale Advanced Technology for Governments
Revenue & Net Income
| Date | Revenue | Net Income | EPS | Revenue Change | Net Income Change | EPS Change | |
|---|---|---|---|---|---|---|---|
| 0 | 2021-03-31 | $7.9B | $609.0M | $4.40 | N/A | N/A | N/A |
| 1 | 2022-03-31 | $8.4B | $466.7M | $3.46 | 6.4% | -23.4% | -21.4% |
| 2 | 2023-03-31 | $9.3B | $271.8M | $2.04 | 10.7% | -41.8% | -41.0% |
| 3 | 2024-03-31 | $10.7B | $605.7M | $4.61 | 15.2% | 122.9% | 126.0% |
| 4 | 2025-03-31 | $12.0B | $605.7M | $4.61 | 12.4% | 0.0% | 0.0% |
| 5 | TTM 2025-03-31 | $9.0B | $742.3M | $6.83 | -24.8% | 22.6% | 48.2% |
| 6 | Average | 4.0% | 16.1% | 22.4% |
EPS
Forecasts
Y/Y % Change
BAH Year-over-Year Growth
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | Average | |
|---|---|---|---|---|---|---|---|---|
| Revenue Growth (%) | 6.4% | 10.7% | 15.2% | 12.4% | -5.0% | 2.6% | 7.0% | |
| Revenue Analysts (#) | 0 | 0 | 0 | 0 | 0 | 6 | 6 | |
| EPS Growth (%) | -23.4% | -41.8% | 122.9% | 0.0% | 15.4% | 5.3% | 13.1% | |
| EPS Analysts (#) | 0 | 0 | 0 | 0 | 0 | 7 | 7 |
Expenses
| Year | Revenue ($) | Cost of Revenue ($) | G&A ($) | SG&A ($) | Facilities / D&A ($) |
|---|---|---|---|---|---|
| 2022 | $8.4B | $3.8B | $1.2B | $1.2B | $145.7M |
| 2023 | $9.3B | $4.1B | $1.5B | $1.5B | $165.0M |
| 2024 | $10.7B | $4.8B | $1.3B | $1.3B | $164.0M |
| 2025 | $12.0B | $5.3B | $1.2B | $1.2B | $165.0M |
| TTM | $11.7B | $5.3B | $1.3B | $1.3B | $163.0M |
| Year | Revenue Change (%) | Cost of Revenue Change (%) | G&A Change (%) | SG&A Change (%) | Facilities / D&A Change (%) |
|---|---|---|---|---|---|
| 2023 | 10.70 | 10.29 | 32.27 | 32.27 | 13.21 |
| 2024 | 15.15 | 14.90 | -16.44 | -16.44 | -0.61 |
| 2025 | 12.36 | 10.45 | -2.73 | -2.73 | 0.61 |
| TTM | -2.29 | 0.60 | 6.12 | 6.12 | -1.21 |
No unmapped expenses.
Balance Sheet
| Metric | Value | |
|---|---|---|
| 0 | Total Assets | $7,170M |
| 1 | Cash | $711M |
| 2 | Total Liabilities | $6,105M |
| 3 | Total Debt | $4,185M |
| 4 | Total Equity | $1,065M |
| 5 | Debt to Equity Ratio | 3.93 |
EPS & Dividend
Valuation
| Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
|---|---|---|---|---|---|---|
| $96.35 | 4.1% | FINVIZ Growth: 2% | Nicks: 7 Finviz: 8 |
Nick's: 0.000 | 1.0 | 14.7 |
| Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
|---|---|---|---|---|---|
| $6.56 EPS | TTM | $42.98 | -55.4% | $53.33 | -44.7% |
| $5.67 EPS | 2026 | $37.15 | -61.4% | $46.09 | -52.2% |
| $5.97 EPS | 2027 | $39.12 | -59.4% | $48.53 | -49.6% |
Implied Growth
| Average | Median | Std Dev | Current | Percentile | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
| Timeframe | ||||||||||
| 1 Year | 7.04% | 7.82% | 6.97% | 8.03% | 0.79% | 1.12% | 7.98% | 8.83% | 84.7% | 76.7% |
| 3 Years | 7.04% | 7.82% | 6.97% | 8.03% | 0.79% | 1.12% | 7.98% | 8.83% | 84.7% | 76.7% |
| 5 Years | 7.04% | 7.82% | 6.97% | 8.03% | 0.79% | 1.12% | 7.98% | 8.83% | 84.7% | 76.7% |
| 10 Years | 7.04% | 7.82% | 6.97% | 8.03% | 0.79% | 1.12% | 7.98% | 8.83% | 84.7% | 76.7% |